Tokyo Tape
Sign in

ADR Biomedical Holdings

3750.TInformation & Communication
Filed as FRACTALE Corporation (2022-06–2022-06), Cytori Cell Research Institute,Inc. (2022-08–2025-11), ADR120S, Inc. (2025-11–2026-06)
Major holders (5%+) · 6
HolderStakeChangeFiled
Hashimoto Masamichi18.50%—2025-03-06
HG CAPITAL CO., LTD.13.14%-2.83pp2024-03-27
FTL Capital Management K.K11.05%—2025-10-22
Catalyst Investment Group Co., Ltd.10.67%+1.79pp2024-07-26
TOKYO WELD CO., LTD.9.22%—2026-05-08
Toshiyasu Horie5.16%-1.98pp2025-03-05

Each holder's own ratio from its most recent large-shareholding report.

Former and minor holders (below 5%) · 7
YOSHIRO KUBOTA4.21%2026-05-08
Naturali Co., Ltd.3.94%2025-07-15
Norio Shirahama3.27%2024-05-31
ACA Inc,2.58%2024-03-22
KEISUKE KUBOTA1.15%2026-05-08
UESHIMA Co., Ltd.0.46%2025-07-15
Kankuro Ueshima0.00%2025-07-15
Ownership history · 27
FiledHolderRatioChangePurpose
2024-02-16AmendedHG CAPITAL CO., LTD.2024-02-16 · amended15.97%newPure investment
2024-02-13AmendedACA Inc,2024-02-13 · amended5.34%-24.73ppPure investment; Participation in management; Business / capital relationship
2024-01-31AmendedACA Inc,2024-01-31 · amended30.07%no changePure investment; Participation in management; Business / capital relationship
2024-01-30AmendedACA Inc,2024-01-30 · amended30.07%no changePure investment; Participation in management; Business / capital relationship
2024-01-30AmendedACA Inc,2024-01-30 · amended30.07%newPure investment; Participation in management; Business / capital relationship
2024-01-19AmendedNorio Shirahama2024-01-19 · amended3.86%newPure investment; Stable shareholder
2024-01-19AmendedToshiyasu Horie2024-01-19 · amended9.03%newPure investment

Each holder in 5% reports, joint holders included. Purpose is classified from the filed text.